Technology
Health
Medical

BioLife Solutions

$18.69
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.47 (2.58%) Today
$0.00 (0.00%) After Hours

Why Robinhood?

You can buy or sell BLFS and other stocks, options, ETFs, and crypto commission-free!

About

BioLife Solutions, Inc. engages in the development, manufacture, and marketing of biopreservation tools for cells and tissues. Its product offerings include proprietary hypothermic storage and cryopreservation freeze media products for cells, tissues, and organs; generic blood stem cell freezing and cell thawing media products; and custom product formulation and custom packaging services. Read More The company was founded by Boris Rubinsky in 1998 and it is headquartered in Bothell, WA.

Employees
54
Headquarters
Bothell, Washington
Founded
1998
Market Cap
341.03M
Price-Earnings Ratio
123.53
Dividend Yield
0.00
Average Volume
229.97K
High Today
$18.71
Low Today
$17.86
Open Price
$18.07
Volume
45.60K
52 Week High
$26.35
52 Week Low
$8.50

Collections

Technology
Health
Medical
Media
Advertising and Marketing
Packaging
Business Services
US

News

Seeking AlphaMay 9

Biolife Solutions' CEO Mike Rice on Q1 2019 Results - Earnings Call Transcript

BioLife Solutions, Inc. (NASDAQ:BLFS) Q1 2019 Earnings Conference Call May 9, 2019 4:30 PM ET Company Participants Mike Rice – President and Chief Executive Officer Roderick de Greef – Chief Financial Officer Conference Call Participants Suraj Kalia – Northland Securities Paul Knight – Janney Montgomery William March – Spring City Partners Operator Good day, ladies and gentlemen and welcome to the BioLife Solutions, Inc. First Quarter Earnings Conference Call. At this time, all participants are in ...

41
PR NewswireMay 9

BioLife Solutions Announces First Quarter 2019 Financial Results

BOTHELL, Wash., May 9, 2019 /PRNewswire/ -- BioLife Solutions, Inc. (NASDAQ: BLFS) ("BioLife" or the "Company"), the leading developer, manufacturer and marketer of proprietary biopreservation media and automated cell thawing media devices for cell and gene therapies, today reported financial results and operational highlights for the three months ended March 31, 2019. Revenue from biopreservation media product sales for the first quarter of 2019 reached a record $5.8 million, an increase of 51% compared w...

42
NasdaqMay 2

BioLife Solutions (BLFS) to Report Q1 Results: Wall Street Expects Earnings Growth

82

Earnings

-$0.06
-$0.02
$0.01
$0.05
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Estimated
$0.03 per share
Actual
$0.02 per share
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.